Skip to main content
Clinical Trials/ISRCTN81577353
ISRCTN81577353
Completed
未知

A prospective, randomised, single centre clinical study comparing cementless Polar stem and the cementless Corail stem in total hip replacement

Joint UCL / UCLH / Royal Free Biomedical Research Unit (UK)0 sites75 target enrollmentMarch 21, 2012

Overview

Phase
未知
Intervention
Not specified
Conditions
Hip osteoarthritis, total hip replacement
Sponsor
Joint UCL / UCLH / Royal Free Biomedical Research Unit (UK)
Enrollment
75
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 21, 2012
End Date
July 1, 2020
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Joint UCL / UCLH / Royal Free Biomedical Research Unit (UK)

Eligibility Criteria

Inclusion Criteria

  • 1\. The surgeon and the patient must agree that total hip replacement (THR) is necessary
  • 2\. The patient must be fit for THR in the opinion of the surgeon and the interdisciplinary team
  • 3\. The indication for THR must be primary osteoarthritis, avascular necrosis, femoral neck fracture, or hip dysplasia
  • 4\. Patients requiring primary arthroplasty
  • 5\. Patients must be aged between 50 \-? 75 years at the time of surgery
  • 6\. Both male and female
  • 7\. The patient must be capable of giving informed consent and express a willingness to comply with the post\-operative review program
  • 8\. The patient must be a permanent resident in an area accessible to the study site

Exclusion Criteria

  • 1\. Post\-traumatic OA (proximal femur fracture)
  • 2\. Post\-infection in respective joint
  • 3\. Prior osteotomy of the affected hip
  • 4\. Patients under treatment for osteoporosis (with bisphosphonate)
  • 5\. OA patients diagnosed Charnley Classification
  • 6\. Patients requiring cortisone medication
  • 7\. Patients whose body mass index is higher than 35
  • 8\. Patients already participating in the RSA hip study.
  • 9\. The individual is unable or unwilling to sign the patient informed consent specific to this study
  • 10\. Previous THR on contra\-lateral side

Outcomes

Primary Outcomes

Not specified

Similar Trials